Accéder au contenu
Merck

Molecular characterization of a novel N-acetylneuraminate lyase from Lactobacillus plantarum WCFS1.

Applied and environmental microbiology (2011-02-15)
Guiomar Sánchez-Carrón, María Inmaculada García-García, Ana Belén López-Rodríguez, Sofía Jiménez-García, Agustín Sola-Carvajal, Francisco García-Carmona, Alvaro Sánchez-Ferrer
RÉSUMÉ

N-Acetylneuraminate lyases (NALs) or sialic acid aldolases catalyze the reversible aldol cleavage of N-acetylneuraminic acid (Neu5Ac) to form pyruvate and N-acetyl-d-mannosamine (ManNAc). In nature, N-acetylneuraminate lyase occurs mainly in pathogens. However, this paper describes how an N-acetylneuraminate lyase was cloned from the human gut commensal Lactobacillus plantarum WCFS1 (LpNAL), overexpressed, purified, and characterized for the first time. This novel enzyme, which reaches a high expression level (215 mg liter(-1) culture), shows similar catalytic efficiency to the best NALs previously described. This homotetrameric enzyme (132 kDa) also shows high stability and activity at alkaline pH (pH > 9) and good temperature stability (60 to 70°C), this last feature being further improved by the presence of stabilizing additives. These characteristics make LpNAL a promising biocatalyst. When its sequence was compared with that of other, related (real and putative) NALs described in the databases, it was seen that NAL enzymes could be divided into four structural groups and three subgroups. The relation of these subgroups with human and other mammalian NALs is also discussed.

MATÉRIAUX
Référence du produit
Marque
Description du produit

Sigma-Aldrich
N-Acetylneuraminic Acid Aldolase from microorganisms, lyophilized powder, ≥20 units/mg protein (biuret)
Sigma-Aldrich
Sialic Acid Aldolase from Escherichia coli K12, recombinant, expressed in E. coli BL21, ≥3.0 units/mg protein